CNE100003ZH1
CNE100003ZH1
GAN&LEE PHARMACEUTICALS CO LTD
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 4.052.146.960 | 3.045.347.805 | 33.1% |
| Cost of Revenue | 978.951.762 | 766.506.269 | 27.7% |
| Gross Profit | 3.073.195.198 | 2.278.841.536 | 34.9% |
| 2.279.562.857 | 1.968.011.713 | 15.8% | |
| Operating Income | 793.632.341 | 310.829.823 | 155.3% |
| Pretax Income | 1.229.805.744 | 630.385.148 | 95.1% |
| Net Income Common Stockholders | 1.143.583.603 | 614.663.847 | 86.1% |
| -- | -- | -- | |
| -- | -- | -- |